A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial
一项在美国和加拿大开展的多中心研究旨在评估罗培干扰素α-2b-njft治疗原发性血小板增多症患者的疗效、安全性和耐受性:EXCEED-ET试验
期刊:Frontiers in Medicine
影响因子:3
doi:10.3389/fmed.2025.1548590
Masarova, Lucia; Reeves, Brandi N; El Chaer, Firas; Foltz, Lynda; Tashi, Tsewang; Abu-Zeinah, Ghaith; Lucas, Jennifer; Halpern, Anna B; Maze, Dawn; Qin, Albert; Safah, Hana; Lan, Fengshuo; O'Connell, Casey L; Goel, Swati; Rein, Lindsay; Fang, Bruno; How, Joan; Babu, Sunil; Li, Zhuoyan; Cerquozzi, Sonia; Oh, Stephen T; Hunter, Anthony M; Podoltsev, Nikolai; Vachhani, Pankit; Yacoub, Abdulraheem; Cunningham, Julia M; Hillis, Christopher; Otoukesh, Salman; Zagrijtschuk, Oleh; Castro, Henry; Bose, Prithviraj